These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16531173)

  • 1. Performance of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women.
    Beksinska M; Smit J; Mabude Z; Vijayakumar G; Joanis C
    Contraception; 2006 Apr; 73(4):386-93. PubMed ID: 16531173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term acceptability of the Reality polyurethane female condom and a synthetic latex prototype: a randomized crossover trial among South African women.
    Smit J; Beksinska M; Vijayakumar G; Mabude Z
    Contraception; 2006 Apr; 73(4):394-8. PubMed ID: 16531174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative crossover study of the PATH Woman's Condom and the FC Female Condom.
    Schwartz JL; Barnhart K; Creinin MD; Poindexter A; Wheeless A; Kilbourne-Brook M; Mauck CK; Weiner DH; Callahan MM
    Contraception; 2008 Dec; 78(6):465-73. PubMed ID: 19014792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakage and acceptability of a polyurethane condom: a randomized, controlled study.
    Frezieres RG; Walsh TL; Nelson AL; Clark VA; Coulson AH
    Fam Plann Perspect; 1998; 30(2):73-8. PubMed ID: 9561872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy of a polyurethane condom: results from a randomized, controlled clinical trial.
    Frezieres RG; Walsh TL; Nelson AL; Clark VA; Coulson AH
    Fam Plann Perspect; 1999; 31(2):81-7. PubMed ID: 10224546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and safety of the second-generation female condom (FC2) versus the Woman's, the VA worn-of-women, and the Cupid female condoms: a randomised controlled non-inferiority crossover trial.
    Beksinska ME; Piaggio G; Smit JA; Wu J; Zhang Y; Pienaar J; Greener R; Zhou Y; Joanis C
    Lancet Glob Health; 2013 Sep; 1(3):e146-52. PubMed ID: 25104263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized noninferiority crossover controlled trial of the functional performance and safety of new female condoms: an evaluation of the Velvet, Cupid2, and FC2.
    Beksinska M; Greener R; Kleinschmidt I; Pillay L; Maphumulo V; Smit J
    Contraception; 2015 Sep; 92(3):261-7. PubMed ID: 26002805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial.
    Macaluso M; Blackwell R; Jamieson DJ; Kulczycki A; Chen MP; Akers R; Kim DJ; Duerr A
    Am J Epidemiol; 2007 Jul; 166(1):88-96. PubMed ID: 17420182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy of a nonlatex condom: results from a randomized, controlled clinical trial.
    Walsh TL; Frezieres RG; Peacock K; Nelson AL; Clark VA; Bernstein L
    Perspect Sex Reprod Health; 2003; 35(2):79-86. PubMed ID: 12729137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male partner involvement and assistance in female condom use.
    Beksinska M; Smit J; Mabude Z; Vijayakumar G; Linda J
    Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):400-3. PubMed ID: 19117256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice makes perfect: reduction in female condom failures and user problems with short-term experience in a randomized trial.
    Beksinska M; Smit J; Joanis C; Hart C
    Contraception; 2012 Aug; 86(2):127-31. PubMed ID: 22264667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials.
    Walsh TL; Frezieres RG; Peacock K; Nelson AL; Clark VA; Bernstein L; Wraxall BG
    Contraception; 2004 Nov; 70(5):407-13. PubMed ID: 15504381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical breakage, slippage and acceptability of a new commercial polyurethane condom: a randomized, controlled study.
    Potter WD; de Villemeur M
    Contraception; 2003 Jul; 68(1):39-45. PubMed ID: 12878286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis.
    Dowdy DW; Sweat MD; Holtgrave DR
    AIDS; 2006 Oct; 20(16):2091-8. PubMed ID: 17053355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study shows Avanti breaks more than latex condoms.
    AIDS Alert; 1997 Sep; 12(9):105-7. PubMed ID: 11364586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The male polyurethane condom: a review of current knowledge.
    Rosenberg MJ; Waugh MS; Solomon HM; Lyszkowski AD
    Contraception; 1996 Mar; 53(3):141-6. PubMed ID: 8689877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom.
    Frezieres RG; Walsh TL
    Contraception; 2000 Jun; 61(6):369-77. PubMed ID: 10958880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The female condom.
    Med Lett Drugs Ther; 1993 Dec; 35(912):123-4. PubMed ID: 8264504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased condom breakage and slippage rates after counseling men at a sexually transmitted infection clinic in Jamaica.
    Steiner MJ; Taylor D; Hylton-Kong T; Mehta N; Figueroa JP; Bourne D; Hobbs M; Behets F
    Contraception; 2007 Apr; 75(4):289-93. PubMed ID: 17362708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional performance study of an adapted design of the woman's condom: a crossover, noninferiority, randomized clinical trial.
    Beksinska M; Greener R; Mphili N; Smit J; Kilbourne-Brook M; Coffey PS
    Eur J Contracept Reprod Health Care; 2019 Jun; 24(3):233-239. PubMed ID: 31112062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.